Serum thrombopoietin levels in patients with fulminant hepatitis.

被引：0
|
作者：
Kato, N
Shiratori, Y
Nita, S
Shiina, S
Ehata, T
Yokosuka, O
Omata, M
机构：
[1] UNIV TOKYO,DEPT INTERNAL MED 2,TOKYO 113,JAPAN
[2] CHIBA UNIV,SCH MED,DEPT INTERNAL MED 1,CHIBA 260,JAPAN
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：832 / 832
页数：1
相关论文
共 50 条
  • [1] Serum interleukin-18 levels in patients with acute and fulminant hepatitis.
    Sato, S
    Abe, K
    Kasai, K
    Kawakami, T
    Sato, A
    Sakasita, Y
    Onodera, M
    Endo, R
    Iwai, M
    Takikawa, Y
    Kato, A
    Suzuki, K
    HEPATOLOGY, 2000, 32 (04) : 397A - 397A
  • [2] Serum vascular endothelial growth factor levels in various liver diseases - Comparison of acute hepatitis and fulminant hepatitis.
    Akiyoshi, F
    Sata, M
    Uchimura, Y
    Mitsuyama, K
    Suzuki, H
    Hanatani, M
    Tanikawa, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1208 - A1208
  • [3] Treatment of hepatitis in fulminant viral hepatitis.
    Yoshiba, M
    Sekiyama, K
    Inoue, K
    HEPATOLOGY, 1998, 28 (04) : 749A - 749A
  • [4] Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis
    Kawasaki, T
    Takeshita, A
    Souda, K
    Kobayashi, Y
    Kikuyama, M
    Suzuki, F
    Kageyama, F
    Sasada, Y
    Shimizu, E
    Murohisa, G
    Koide, S
    Yoshimi, T
    Nakamura, H
    Ohno, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (07): : 1918 - 1922
  • [5] Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis
    Kawasaki, T
    Kageyama, F
    Murohisa, G
    Shimizu, E
    Suzuki, F
    Kikuyama, M
    Souda, K
    Kobayashi, Y
    Yoshimi, T
    Takeshita, A
    Ohno, R
    HEPATOLOGY, 1996, 24 (04) : 1065 - 1065
  • [6] Chemokine expression in fulminant hepatitis.
    Leifeld, L
    Purr, I
    Janberg, K
    Dumoulin, FL
    Trautwein, C
    Sauerbruch, T
    Spengler, U
    GASTROENTEROLOGY, 2000, 118 (04) : A920 - A920
  • [7] Level of replication and genotypes of hepatitis A virus in fulminant and non-fulminant hepatitis.
    Rezende, G
    Roque, AM
    Gigou, M
    Dussaix, E
    Challine, D
    Samuel, D
    Feray, C
    HEPATOLOGY, 2001, 34 (04) : 487A - 487A
  • [8] Serum levels of secretory immunoglobulin A correlate with fibrosis in patients with HCV chronic hepatitis.
    Sgarbi, D
    DiFrancesco, V
    Negri, M
    Zagni, I
    Brunelli, S
    Angelini, G
    Talamini, G
    Bovo, P
    Frulloni, L
    Moi, A
    Cavallini, G
    GASTROENTEROLOGY, 1997, 112 (04) : A1380 - A1380
  • [9] The influence of aging on immunological parameters in patients with fulminant and severe acute hepatitis.
    Naritomi, T
    Hasegawa, K
    Iizuka, A
    Yamaguchi, N
    Sasaki, M
    Kanai, N
    Taniai, M
    Tokushige, K
    Hashimoto, E
    Yamauchi, K
    Hayashi, N
    HEPATOLOGY, 1999, 30 (04) : 676A - 676A
  • [10] Prognostic importance of soluble CD163 in patients with fulminant hepatitis.
    Hiraoka, A
    Horiike, N
    Akbar, SMF
    Matsuyama, T
    Onji, M
    HEPATOLOGY, 2003, 38 (04) : 543A - 543A
12345